Nishida, K.; Watanabe, H.; Murata, R.; Tokumaru, K.; Fujimura, R.; Oshiro, S.; Nagasaki, T.; Miyahisa, M.; Hiramoto, Y.; Nosaki, H.;
et al. Recombinant Long-Acting Thioredoxin Ameliorates AKI to CKD Transition via Modulating Renal Oxidative Stress and Inflammation. Int. J. Mol. Sci. 2021, 22, 5600.
https://doi.org/10.3390/ijms22115600
AMA Style
Nishida K, Watanabe H, Murata R, Tokumaru K, Fujimura R, Oshiro S, Nagasaki T, Miyahisa M, Hiramoto Y, Nosaki H,
et al. Recombinant Long-Acting Thioredoxin Ameliorates AKI to CKD Transition via Modulating Renal Oxidative Stress and Inflammation. International Journal of Molecular Sciences. 2021; 22(11):5600.
https://doi.org/10.3390/ijms22115600
Chicago/Turabian Style
Nishida, Kento, Hiroshi Watanabe, Ryota Murata, Kai Tokumaru, Rui Fujimura, Shun Oshiro, Taisei Nagasaki, Masako Miyahisa, Yuto Hiramoto, Hiroto Nosaki,
and et al. 2021. "Recombinant Long-Acting Thioredoxin Ameliorates AKI to CKD Transition via Modulating Renal Oxidative Stress and Inflammation" International Journal of Molecular Sciences 22, no. 11: 5600.
https://doi.org/10.3390/ijms22115600
APA Style
Nishida, K., Watanabe, H., Murata, R., Tokumaru, K., Fujimura, R., Oshiro, S., Nagasaki, T., Miyahisa, M., Hiramoto, Y., Nosaki, H., Imafuku, T., Maeda, H., Fukagawa, M., & Maruyama, T.
(2021). Recombinant Long-Acting Thioredoxin Ameliorates AKI to CKD Transition via Modulating Renal Oxidative Stress and Inflammation. International Journal of Molecular Sciences, 22(11), 5600.
https://doi.org/10.3390/ijms22115600